University of Minnesota Pediatric Hematology/Oncology

Topics

• Hematopoietic Stem Cell Transplantation 345
• Childhood Cancer Survivors' Quality of Life 195
• Acute Lymphoblastic Leukemia research 127
• Acute Myeloid Leukemia Research 56
• CAR-T cell therapy research 53
• Sarcoma Diagnosis and Treatment 43
• Immunotherapy and Immune Responses 40
• Congenital Diaphragmatic Hernia Studies 39
• Hemoglobinopathies and Related Disorders 38
• Neuroblastoma Research and Treatments 38
• Autoimmune and Inflammatory Disorders Research 37
• Immune Cell Function and Interaction 36

Most cited

1. Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 326 citations · Heather Stefanski

2. Current Activity Trends and Outcomes in Hematopoietic Cell Transplantation and Cellular Therapy - A Report from the CIBMTR.

   Transplantation and cellular therapy · 2025 · 87 citations · Heather Stefanski

3. Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated Donors.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024 · 100 citations · Heather Stefanski

4. Diagnostic guidelines for familial hemophagocytic lymphohistiocytosis revisited.

   Blood · 2024 · 87 citations · Ashish Kumar

5. Anticoagulation in adult patients supported with extracorporeal membrane oxygenation: guidance from the Scientific and Standardization Committees on Perioperative and Critical Care Haemostasis and Thrombosis of the International Society on Thrombosis and Haemostasis.

   Journal of thrombosis and haemostasis : JTH · 2023 · 95 citations · Marie Steiner

6. Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen Receptor Consortium Report.